Old barriers need not apply: Opening doors for new contraceptives in the developing world

Contraception

Volumn 85, Issue 1, 2012, Pages 11-14

  Greene, Elizabeth ^a   Stanback, John ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER INTRAUTERINE DEVICE; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE;

ATTITUDE TO HEALTH; CHILDBIRTH; CONTRACEPTION; DEVELOPING COUNTRY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FAMILY PLANNING; FOLLOW UP; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; INFECTION RISK; INTRAUTERINE CONTRACEPTIVE DEVICE; MATERNAL AGE; MEDICAL EXAMINATION; NOTE; PARITY; PELVIC EXAMINATION; PELVIC INFLAMMATORY DISEASE; PREGNANCY; SEXUALLY TRANSMITTED DISEASE; SOCIAL MARKETING; TREATMENT INDICATION;

CONTRACEPTIVE AGENTS, FEMALE; DEVELOPING COUNTRIES; DRUG IMPLANTS; HEALTH SERVICES ACCESSIBILITY; INTRAUTERINE DEVICES, MEDICATED; MEDROXYPROGESTERONE ACETATE;

EID: 82755193811     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2011.05.004     Document Type: Note

References (33)

1. M. Campbell, N. Sahin-Hodoglugil, and M. Potts Barriers to fertility regulation: a review of the literature Stud Fam Plann 37 2006 87 98 (Pubitemid 43905632)
2. J. Konje, and O. Ladipo Barriers to uptake and use of modern methods of contraception in developing countries Int J Gynaecol Obstet 65 1999 287 294 (Pubitemid 29281584)
3. J. Bertrand, K. Hardee, R. Magnani, and M. Angle Access, quality of care and medical barriers in family planning programs Int Fam Plan Perspect 1995 64 74
4. J. Shelton, M. Angle, and R. Jacobstein Medical barriers to access to family planning Lancet 340 1992 1334
5. K. Miller, R. Miller, G. Fassihian, and H. Jones How providers restrict access to family planning methods: results from five African countries Clinic-based family planning and reproductive health services in Africa: findings from situation analysis studies 1998
6. I. Speizer, D. Hotchkiss, R. Magnani, B. Hubbard, and K. Nelson Do service providers in Tanzania unnecessarily restrict clients' access to contraceptive methods? Int Fam Plan Perspec 26 2000 13 42
7. J. Stanback, and K. Twum-Baah Why do family planning providers restrict access to services? An examination in Ghana Int Fam Plan Perspect 27 2001 37 41 (Pubitemid 33721261)
8. J. Stanback, F. Diabate, T. Dieng, T. de Morales, S. Cummings, and M. Traoré Ruling out pregnancy among family planning clients: the impact of a checklist in three countries Stud Fam Plann 36 2005 311 315 (Pubitemid 44883491)
9. J. Stanback, A. Thompson, K. Hardee, and B. Janowitz Menstruation requirements: a significant barrier to contraceptive access in developing countries Stud Fam Plann 1997 245 250
10. E. Seiber, J. Bertrand, and T. Sullivan Changes in contraceptive method mix in developing countries Int Fam Plan Perspect 33 2007 117 123 (Pubitemid 350020559)
11. F. Lakha, C. Henderson, and A. Glasier The acceptability of self-administration of subcutaneous Depo-Provera Contraception 72 2005 14 18 (Pubitemid 40827112)
12. M. Steiner, C. Kwok, and J. Stanback Injectable contraception: what should the longest interval be for reinjections? Contraception 77 2008 410 414
13. World Health Organization. Selected practice recommendations for contraceptive use: 2008 update [cited April 18, 2011]; Available from http://whqlibdoc.who.int/hq/2008/WHO-RHR-08.17-eng.pdf
14. J. Baumgartner, C. Morroni, and R. Mlobeli Timeliness of contraceptive reinjections in South Africa and its relation to unintentional discontinuation Int Fam Plan Perspect 33 2007 66 74 (Pubitemid 47180980)
15. S. Malarcher, O. Meirik, E. Lebetkin, I. Shah, J. Spieler, and J. Stanback Provision of DMPA by community health workers: what the evidence shows Contraception 2010
16. World Health Organization USAID FHI. Community-based health workers can safely and effectively administer injectable contraceptives: conclusions from a technical consultation 2010 FHI Research Triangle Park (NC)
17. D. Hubacher, J. Kimani, M. Steiner, M. Solomon, and M. Ndugga Contraceptive implants in Kenya: current status and future prospects Contraception 75 2007 468 473 (Pubitemid 46805057)
18. US Agency for International Development. USAID health: family planning, news/info, pearls, family planning pearls [cited 2009 February 8, 2011]; Available from http://www.usaid.gov/our-work/global-health/pop/news/fampearls. html#sino2 2009
19. A. Gelaw Scaling up access to family planning in southern Ethiopia [cited January 11, 2010]; Available from www.unfpa.org/public/news/pid/4675 2010
20. J.W. Townsend, and R. Jacobstein The changing position of IUDs in reproductive health services in developing countries: opportunities and challenges Contraception 75 2007 S35 S40 (Pubitemid 46795436)
21. S. Townsend Attitudes, regulations hinder use of the pill Network 13 1993 6
22. C. Chrisman, P. Ribeiro, and V.K. Dalton The levonorgestrel-releasing intrauterine system: an updated review of the contraceptive and noncontraceptive uses Clin Obstet Gynecol 50 2007 886
23. V. Grigorieva, M. Chen-Mok, M. Tarasova, and A. Mikhailov Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas Fertil Steril 79 2003 1194 1198 (Pubitemid 36547859)
24. R. Vernon Nurse auxiliaries as providers of intrauterine devices for contraception in Guatemala and Honduras Reprod Health Matters 17 2009 51 60
25. N. Eren, R. Ramos, and R. Gray Physicians vs. auxiliary nurse-midwives as providers of IUD services: a study in Turkey and the Philippines Stud Fam Plann 14 1983 43 47
26. G. Farr, R. Rivera, and R. Amatya Non-physician insertion of IUDs: clinical outcomes among TCu380A insertions in three developing-country clinics Adv Contracept 14 1998 45 57 (Pubitemid 28151975)
27. J. Shelton Risk of clinical pelvic inflammatory disease attributable to an intrauterine device Lancet 357 2001 443 (Pubitemid 32156147)
28. S.K. Sinei, C.S. Morrison, C. Sekadde-Kigondu, M. Allen, and D. Kokonya Complications of use of intrauterine devices among HIV-1-infected women Lancet 351 1998 1238 1241 (Pubitemid 28181963)
29. C.S. Morrison, C. Sekadde Kigondu, S.K. Sinei, D.H. Weiner, C. Kwok, and D. Kokonya Is the intrauterine device appropriate contraception for HIV 1 infected women? BJOG 108 2001 784 790 (Pubitemid 32695308)
30. P. Lehtovirta, J. Paavonen, and O. Heikinheimo Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women Contraception 75 2007 37 39 (Pubitemid 44854865)
31. O. Heikinheimo, P. Lehtovirta, J. Suni, and J. Paavonen The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women - effects on bleeding patterns, ovarian function and genital shedding of HIV Hum Reprod 21 2006 2857 2861 (Pubitemid 44566998)
32. K.W. Aradhya Mera, May 2007: providing intrauterine devices to women at risk of sexually transmitted infections [cited April 18, 2011]; Available from http://www.fhi.org/en/RH/Pubs/mera/IUDs4Women-with-STIs.htm
33. C.S. Morrison, L. Murphy, C. Kwok, and D.H. Weiner Identifying appropriate IUD candidates in areas with high prevalence of sexually transmitted infections Contraception 75 2007 185 192 (Pubitemid 46217182)